No results for ‘’
Quick Heal Technologies Ltd
₹175.03
(0.62%)
Tue, 16 Jun 2026, 09:36 am
Technology Services
Packaged Software
24.5KQuick Heal Technologies EV/EBITDA Ratio
| Particulars | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 0 | 23.45 | 31.33 | 22.53 | 17.33 | 7.16 | 11.21 | 12.74 | 116.74 | 104.96 | 313.70 |
| Price to book ratio | 0 | 0 | 0 | 0 | 2.42 | 2.51 | 2.58 | 2.02 | 0.81 | 1.59 | 1.64 | 1.68 | 5.76 | 3.51 |
| Price to sales ratio | 0 | 0 | 0 | 0 | 4.50 | 5.56 | 5.87 | 5.05 | 1.86 | 3.60 | 3.10 | 2.69 | 8.72 | 5.66 |
| Price to cash flow ratio | 0 | 0 | 0 | 0 | 16.38 | 27.90 | 16.51 | 18.08 | 6.13 | 11.24 | 12.72 | 22.87 | 131.96 | 0 |
| Enterprise value | 0 | 0 | 0 | 0 | 978Cr | 1282Cr | 1418Cr | 1097Cr | 178Cr | 731Cr | 707Cr | 559Cr | 2324Cr | 1388Cr |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 0 | 9.49 | 13.91 | 11.08 | 8.46 | 1.90 | 5.07 | 6.46 | 114.09 | 117.13 | 0 |
| Debt to equity ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Return on equity % | 0 | 31.05 | 18.91 | 16.21 | 12.05 | 8.39 | 11.98 | 12.13 | 10.38 | 15.33 | 12.06 | 1.22 | 5.66 | 1.15 |
Quick Heal Technologies Ltd Enterprise Value to EBITDA Ratio
The Quick Heal Technologies Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Quick Heal Technologies Ltd's valuation, profitability, and overall financial performance. Tracking the Quick Heal Technologies Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Quick Heal Technologies Ltd (NSE: QUICKHEAL, BSE: 539678) is currently trading at ₹175.03, with a market capitalization of ₹946.36Cr. As a leading company in the Technology services sector and Packaged software industry, monitoring the Quick Heal Technologies Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.
Quick Heal Technologies Ltd Enterprise Value to EBITDA Ratio Current Value
The current Quick Heal Technologies Ltd Enterprise Value to EBITDA Ratio stands at 0.
The Quick Heal Technologies Ltd Enterprise Value to EBITDA Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Quick Heal Technologies Ltd Enterprise Value to EBITDA Ratio Historical Trend
The Quick Heal Technologies Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:
- 2024: 0
- 2023: 117.13
- 2022: 114.09
- 2021: 6.46
- 2020: 5.07
The decline in Quick Heal Technologies Ltd Enterprise Value to EBITDA Ratio indicates improving financial efficiency or better earnings growth.
What Quick Heal Technologies Ltd Enterprise Value to EBITDA Ratio Indicates for Investors
The Quick Heal Technologies Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Quick Heal Technologies Ltd.
Quick Heal Technologies Ltd Enterprise Value to EBITDA Ratio Analysis Summary
The Quick Heal Technologies Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Quick Heal Technologies Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Quick Heal Technologies Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.